Table 2 Sarcopenia defining parameters in men and women living with HIV on and not on statins.
Men | Women | |||||
|---|---|---|---|---|---|---|
PLWH not on statins (n = 22) | PLWH on statins (n = 22) | p | PLWH not on statins (n = 30) | PLWH on statins (n = 30) | p | |
Age (years) | 53.5 ± 7.9 | 53.4 ± 8.0 | 0.98 | 54.2 ± 8.5 | 54.3 ± 8.8 | 0.95 |
Body mass index (kg/m2) | 26.9 ± 2.3 | 29.1 ± 5.2 | 0.07 | 29.9 ± 6.4 | 28.4 ± 7.0 | 0.78 |
Time living with HIV (months) | 144.2 ± 99.0 | 165.1 ± 88.4 | 0.47 | 154.6 ± 90.1 | 159.3 ± 88.5 | 0.88 |
Time of ART use (months) | 122.5 ± 79.1 | 154.1 ± 83.2 | 0.20 | 132.8 ± 82.7 | 150.7 ± 90.3 | 0.78 |
Time under statins (months) | – | 53.4 ± 43.2 | – | 45.3 ± 38.4 | 0.47# | |
Body composition | ||||||
Fat mass (kg) | 20.5 ± 5.7 | 24.5 ± 12.0 | 0.19 | 29.2 ± 12.2 | 25.7 ± 11.2 | 0.29 |
Fat mass (%) | 26.2 ± 4.9 | 27.5 ± 7.8 | 0.51 | 39.7 ± 7.4 | 36.3 ± 6.8 | 0.09 |
ASM (kg) | 26.4 ± 1.9 | 28.4 ± 3.1 | 0.04 | 20.4 ± 4.1 | 18.9 ± 4.7 | 0.21 |
ASM/h2 (kg/m2) | 8.5 ± 0.5 | 8.9 ± 1.1 | 0.09 | 7.1 ± 1.0 | 6.7 ± 1.7 | 0.37 |
Low ASM/h2 (%) | 0 (0) | 1 (4) | 0.92 | 2 (7) | 4 (13) | 0.46 |
Muscle strength | ||||||
Handgrip Strength (kg) | 37.1 ± 8.3 | 42.1 ± 8.8 | 0.05 | 24.6 ± 5.4 | 24.7 ± 6.5 | 0.93 |
Low Handgrip Strength (%) | 2 (9) | 1 (3) | 0.48 | 2 (6) | 2 (6) | 1 |
Physical function | ||||||
Balance (score) | 3.8 ± 0.7 | 3.8 ± 0.5 | 0.98 | 3.6 ± 0.8 | 3.7 ± 0.6 | 0.87 |
Gait speed (m/s) | 1.27 ± 0.19 | 1.07 ± 0.16 | < 0.01 | 1.22 ± 0.20 | 1.28 ± 0.17 | 0.21 |
Chair stand (s) | 14.4 ± 4.8 | 11.9 ± 3.5 | 0.05 | 14.4 ± 6.4 | 14.5 ± 4.8 | 0.98 |
SPPB (score) | 9.5 ± 2.1 | 10.9 ± 1.3 | 0.01 | 9.8 ± 2.1 | 9.6 ± 2.0 | 0.91 |
Low SPPB score (%) | 6 (27) | 2 (6) | 0.03 | 8 (26) | 6 (20) | 0.65 |